These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 29584564

  • 1. Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample.
    Augello G, Balasus D, Fusilli C, Mazza T, Emma MR, Giannitrapani L, Agliastro R, Cervello M, Montalto G.
    OMICS; 2018 Apr; 22(4):274-282. PubMed ID: 29584564
    [Abstract] [Full Text] [Related]

  • 2. Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment.
    Huang CF, Huang CY, Yeh ML, Wang SC, Chen KY, Ko YM, Lin CC, Tsai YS, Tsai PC, Lin ZY, Chen SC, Dai CY, Huang JF, Chuang WL, Yu ML.
    EBioMedicine; 2017 Feb; 15():81-89. PubMed ID: 27998720
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients.
    Marangon CG, de Bitencorte JT, Michita RT, Lunge VR, Dos Santos DC, Álvares-da-Silva MR, Simon D.
    Pathol Oncol Res; 2020 Jul; 26(3):1519-1525. PubMed ID: 31471884
    [Abstract] [Full Text] [Related]

  • 5. Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication.
    Huang CF, Wang SC, Yeh ML, Huang CI, Tsai PC, Lin ZY, Chen SC, Dai CY, Huang JF, Chuang WL, Chen A, Yu ML.
    J Gastroenterol Hepatol; 2019 Jan; 34(1):249-255. PubMed ID: 29932235
    [Abstract] [Full Text] [Related]

  • 6. Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk.
    Lo PH, Urabe Y, Kumar V, Tanikawa C, Koike K, Kato N, Miki D, Chayama K, Kubo M, Nakamura Y, Matsuda K.
    PLoS One; 2013 Jan; 8(4):e61279. PubMed ID: 23593449
    [Abstract] [Full Text] [Related]

  • 7. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.
    Kumar V, Yi Lo PH, Sawai H, Kato N, Takahashi A, Deng Z, Urabe Y, Mbarek H, Tokunaga K, Tanaka Y, Sugiyama M, Mizokami M, Muroyama R, Tateishi R, Omata M, Koike K, Tanikawa C, Kamatani N, Kubo M, Nakamura Y, Matsuda K.
    PLoS One; 2012 Jan; 7(9):e44743. PubMed ID: 23024757
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. SNP rs2596542G>A in MICA is associated with risk of hepatocellular carcinoma: a meta-analysis.
    Wang H, Cao H, Xu Z, Wang D, Zeng Y.
    Biosci Rep; 2019 May 31; 39(5):. PubMed ID: 30967497
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants.
    Tong HV, Toan NL, Song LH, Bock CT, Kremsner PG, Velavan TP.
    J Viral Hepat; 2013 Oct 31; 20(10):687-98. PubMed ID: 24010643
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases.
    Mohamed AA, Elsaid OM, Amer EA, Elosaily HH, Sleem MI, Gerges SS, Saleh MA, El Shimy A, El Abd YS.
    J Adv Res; 2017 Jul 31; 8(4):343-349. PubMed ID: 28417047
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetic Polymorphism of Epidermal Growth Factor rs4444903 Influences Susceptibility to HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma in a Chinese Han Population.
    Zhang S, Qiao K, Trieu C, Huo Z, Dai Q, Du Y, Lu W, Hou W.
    Clin Lab; 2017 Apr 01; 63(4):845-850. PubMed ID: 28397482
    [Abstract] [Full Text] [Related]

  • 16. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
    Jadid FZ, Chihab H, Alj HS, Elfihry R, Zaidane I, Tazi S, Badre W, Marchio A, El Filali KM, Tahiri M, Saile R, Pineau P, Ezzikouri S, Benjelloun S.
    Infect Genet Evol; 2018 Dec 01; 66():1-8. PubMed ID: 30172885
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma.
    Hai H, Tamori A, Thuy LTT, Yoshida K, Hagihara A, Kawamura E, Uchida-Kobayashi S, Morikawa H, Enomoto M, Murakami Y, Kawada N.
    Sci Rep; 2017 Sep 19; 7(1):11912. PubMed ID: 28928439
    [Abstract] [Full Text] [Related]

  • 19. Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma.
    Li H, Liu F, Zhu H, Zhou X, Lu J, Chang H, Hu J.
    Med Sci Monit; 2016 Feb 19; 22():549-53. PubMed ID: 26893439
    [Abstract] [Full Text] [Related]

  • 20. Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.
    Audureau E, Carrat F, Layese R, Cagnot C, Asselah T, Guyader D, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Chazouillères O, Mallat A, Grangé JD, Attali P, d'Alteroche L, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Pol S, Nahon P, ANRS CO12 CirVir group.
    J Hepatol; 2020 Dec 19; 73(6):1434-1445. PubMed ID: 32615276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.